The Current Ratio as of November 2024 (TTM) for Rallybio Corporation (RLYB) is 7.52

According to Rallybio Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 7.52. This represents a change of -31.28% compared to the average of 10.94 of the last 4 quarters.

Rallybio Corporation (RLYB) Historical Current Ratio (quarterly & annually)

How has RLYB Current Ratio performed in the past?

The mean historical Current Ratio of Rallybio Corporation over the last ten years is 17.28. The current 7.52 Current Ratio has changed 4.25% with respect to the historical average. Over the past ten years (40 quarters), RLYB's Current Ratio was at its highest in in the March 2022 quarter at 28.93. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Rallybio Corporation (RLYB) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Rallybio Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Rallybio Corporation (RLYB) Average Current Ratio

How has RLYB Current Ratio performed in the past?

The current Current Ratio of Rallybio Corporation (RLYB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Rallybio Corporation (RLYB) Current Ratio vs. Peers

How is RLYB’s Current Ratio compared to its peers?

Rallybio Corporation’s Current Ratio is less than Century Therapeutics, Inc. (10.62), less than Edgewise Therapeutics, Inc. (30.24), greater than C4 Therapeutics, Inc. (6.31), less than Mineralys Therapeutics, Inc. (11.20), less than Cullinan Oncology, Inc. (28.87), less than Molecular Partners AG (14.58), less than AN2 Therapeutics, Inc. (10.61), less than Pharvaris N.V. (18.45), greater than PepGen Inc. (7.45), less than PMV Pharmaceuticals, Inc. (19.22), greater than Opthea Limited (2.94), less than Third Harmonic Bio, Inc. (41.13), greater than Monte Rosa Therapeutics, Inc. (6.56), less than Eliem Therapeutics, Inc. (60.41), less than MediciNova, Inc. (18.24),

Build a custom stock screener for Rallybio Corporation (RLYB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rallybio Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rallybio Corporation (RLYB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rallybio Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.